Feedback / Questions
plamotamab (XmAb13676) - J&J
Plamotamab: Expiry of patents in US/ex-US in 2035
(Xencor)
-
Mar 1, 2023 -
Annual Report 2022
Patent
•
Hematological Malignancies • Oncology
https://investors.xencor.com/static-files/000fb01e-4592-43c0-b653-0e18f12108fe
Mar 1, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious